Total Payments
$477,585
2024 Payments
$50,192
Companies
8
Transactions
376
Payment Breakdown by Category
Consulting$273,120 (57.2%)
Other$125,685 (26.3%)
Travel$60,601 (12.7%)
Research$9,478 (2.0%)
Food & Beverage$8,702 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $273,120 | 86 | 57.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $95,258 | 28 | 19.9% |
| Travel and Lodging | $60,601 | 148 | 12.7% |
| Honoraria | $29,627 | 10 | 6.2% |
| Unspecified | $9,478 | 7 | 2.0% |
| Food and Beverage | $8,702 | 96 | 1.8% |
| Grant | $800.00 | 1 | 0.2% |
Payments by Type
General
$468,107
369 transactions
Research
$9,478
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $181,696 | 110 | $0 (2024) |
| SANOFI PASTEUR INC. | $110,494 | 98 | $0 (2024) |
| GlaxoSmithKline, LLC. | $56,085 | 51 | $0 (2024) |
| Merck Sharp & Dohme LLC | $49,556 | 72 | $0 (2024) |
| Seqirus USA Inc | $40,398 | 19 | $0 (2023) |
| ModernaTX, Inc. | $35,765 | 13 | $0 (2024) |
| SOBI, INC | $2,280 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $1,312 | 12 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50,192 | 30 | ModernaTX, Inc. ($18,298) |
| 2023 | $65,880 | 40 | PFIZER INC. ($41,400) |
| 2022 | $68,488 | 34 | PFIZER INC. ($20,842) |
| 2021 | $32,708 | 18 | PFIZER INC. ($13,930) |
| 2020 | $46,180 | 31 | SANOFI PASTEUR INC. ($15,392) |
| 2019 | $77,325 | 96 | SANOFI PASTEUR INC. ($31,896) |
| 2018 | $38,668 | 34 | Sanofi Pasteur Inc. ($18,319) |
| 2017 | $98,144 | 93 | PFIZER INTERNATIONAL LLC ($46,606) |
All Payment Transactions
376 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| 11/06/2024 | GlaxoSmithKline, LLC. | — | Grant | Cash or cash equivalent | $800.00 | General |
| 11/06/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $252.82 | General |
| 11/06/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | Cash or cash equivalent | $36.77 | General |
| 11/05/2024 | PFIZER INC. | PENBRAYA (Biological) | Travel and Lodging | Cash or cash equivalent | $67.50 | General |
| Category: VACCINES | ||||||
| 11/04/2024 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $728.00 | General |
| 10/19/2024 | SANOFI PASTEUR INC. | — | Food and Beverage | In-kind items and services | $49.61 | General |
| 10/16/2024 | PFIZER INC. | TRUMENBA (Biological) | — | In-kind items and services | $1,400.00 | Research |
| Study: TRUMENBA CLINICAL PUBLICATION PROGRAM • Category: VACCINES | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $145.81 | General |
| 10/16/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $130.47 | General |
| 10/16/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $50.06 | General |
| 10/15/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 10/10/2024 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $970.00 | General |
| 10/01/2024 | PFIZER INC. | PENBRAYA (Biological) | Consulting Fee | Cash or cash equivalent | $5,625.00 | General |
| Category: VACCINES | ||||||
| 09/25/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $2,557.50 | General |
| 09/12/2024 | ModernaTX, Inc. | Moderna Covid-19 Vaccine (Biological) | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 09/11/2024 | PFIZER INC. | PENBRAYA (Biological) | Travel and Lodging | In-kind items and services | $742.42 | General |
| Category: VACCINES | ||||||
| 09/11/2024 | PFIZER INC. | PENBRAYA (Biological) | Travel and Lodging | In-kind items and services | $523.89 | General |
| Category: VACCINES | ||||||
| 09/11/2024 | PFIZER INC. | PENBRAYA (Biological) | Food and Beverage | In-kind items and services | $336.95 | General |
| Category: VACCINES | ||||||
| 09/11/2024 | PFIZER INC. | PENBRAYA (Biological) | Travel and Lodging | In-kind items and services | $208.65 | General |
| Category: VACCINES | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $1,000.88 | General |
| 09/09/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $2,092.50 | General |
| 07/01/2024 | PFIZER INC. | TRUMENBA (Biological) | — | In-kind items and services | $1,900.00 | Research |
| Study: MENINGOCOCCAL VACCINE B RFHBPAFHBPB CLINICAL PUBLICATION PROGRAM • Category: VACCINES | ||||||
| 07/01/2024 | PFIZER INC. | TRUMENBA (Biological) | — | In-kind items and services | $1,900.00 | Research |
| Study: MENINGOCOCCAL VACCINE B RFHBPAFHBPB CLINICAL PUBLICATION PROGRAM • Category: VACCINES | ||||||
| 06/19/2024 | ModernaTX, Inc. | Moderna Covid-19 Vaccine (Biological) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Infections and Infectious Diseases | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| MENINGOCOCCAL VACCINE B RFHBPAFHBPB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $3,800 | 2 |
| MENINGOCOCCAL B CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $3,200 | 1 |
| TRUMENBA CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $1,400 | 1 |
About Dr. Gary Marshall, MD
Dr. Gary Marshall, MD is a Pediatrics healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1720062268.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Marshall, MD has received a total of $477,585 in payments from pharmaceutical and medical device companies, with $50,192 received in 2024. These payments were reported across 376 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($273,120).
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Infectious Diseases
- Location Louisville, KY
- Active Since 11/29/2005
- Last Updated 03/26/2024
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1720062268
Products in Payments
- TRUMENBA (Biological) $71,335
- NO PRODUCT DISCUSSED (Drug) $41,866
- Moderna Covid-19 Vaccine (Biological) $16,600
- MENACTRA (Drug) $16,164
- PENBRAYA (Biological) $13,208
- ABRYSVO (Biological) $10,823
- PREVNAR 13 (Biological) $10,360
- BEXSERO (Biological) $9,955
- FLUCELVAX QUADRIVALENT (Biological) $8,700
- FLUZONE QUADRIVALENT (Biological) $8,507
- FLUZONE QUADRIVALENT (Drug) $6,715
- PREVNAR 20 (Biological) $6,105
- MENACYW CONJUGATE VACCINE (Drug) $5,590
- PREVNAR - 13 (Biological) $5,583
- COMIRNATY (Biological) $4,642
- Fluad Quadrivalent (Biological) $4,024
- SYNAGIS (Drug) $2,280
- V114 (Biological) $1,394
- GARDASIL (Biological) $1,176
- VAXELIS (Biological) $940.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Louisville
Danny Stewart, Md, MD
Pediatrics — Payments: $482,201
Pediatrics $482,201
Ashok Raj, Md, MD
Pediatrics — Payments: $178,221
Pediatrics $178,221
Nemr Eid, Md, MD
Pediatrics — Payments: $78,416
Pediatrics $78,416
Dr. Christian Berkhahn, Md, Ms, MD, MS
Pediatrics — Payments: $63,289
Pediatrics $63,289
Maurice Allgeier, Md, MD
Pediatrics — Payments: $34,515
Pediatrics $34,515
Katherine Mccormack, Md, MD
Pediatrics — Payments: $33,867
Pediatrics $33,867